Glioma patients with high levels of TOPK have poor survival outcome compared with those with low levels of TOPK in HGG or LGG, and patients with low TOPK expression, whether HGG or LGG, had good survival outcome, which suggests that TOPK serves as a prognostic factor regardless of WHO grade in glioma. This evidence concerns the gene PBK and glioma.